LB
LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
$42.47 +0.59% (+$0.25)
1M -11.91%
Market Cap $1.22B
P/E Ratio -
Div. Yield -
ROE 25.91%
Piotroski F-Score Weak
2/9Valuation
56 /100
Fair P/B 3.66x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 25.91%
ROA 23.69%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 15.08x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
21 /100
Unstable EPS volatility 567.68%
Profitable years 0
Beta 0.42x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LBRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Heather D. Turner
Employees
49
Headquarters
New York
Upcoming events
05 NOV
Earnings
Upcoming earnings report